RWD58 Real-World Evidence (RWE) Opportunities to Enhance Local Decision-Making in Oncology for Emerging Markets: A Multi-Regional Oncologist & Payer Committee Perspective

Abstract

Most countries in Emerging Markets follow guidance from the FDA and EMA for RWE generation and use. In these countries, there is demand amongst healthcare stakeholders to grow regional RWE capabilities to support clinician, payer, and regulator decision-making in oncology. This presentation aims to provide: perspectives on the current oncology RWE landscape in these countries; identification and prioritization of high-impact RWE opportunities; and, considerations for implementing the highest-priority opportunity.